Company
Corcept Therapeutics
Corcept Therapeutics has 23 drugs tracked on RxWires: 1 post-market, 1 approved, 1 in Phase 3, 5 in Phase 2, 3 in Phase 1/2, 12 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Mifepristone 300 MG [Korlym] | Post-Market | Hypercortisolism |
| MIFEPRISTONE | Approved | |
| Relacorilant 150 mg | Phase 3 | Ovarian Neoplasm |
| Mifepristone 1200 mg daily | Phase 2 | Treatment-resistant PTSD |
| Miricorlilant | Phase 2 | Antipsychotic-induced Weight Gain (AIWG) |
| Dazucorilant 300 mg | Phase 2 | Amyotrophic Lateral Sclerosis |
| Miricorilant | Phase 2 | Nonalcoholic Steatohepatitis (NASH) |
| Relacorilant 150 mg once daily (QD) | Phase 2 | Ovarian Cancer |
| Relacorilant with nab-paclitaxel | Phase 1/2 | Solid Tumors |
| Exicorilant | Phase 1/2 | Metastatic Castration-Resistant Prostate Cancer |
| Nenocorilant 200 mg | Phase 1/2 | Neoplasms |
| Relacorilant under fasted conditions | Phase 1 | Healthy |
| CORT125281, 40mg, fasted | Phase 1 | Healthy |
| Relacorilant Fasted | Phase 1 | Healthy |
| 14C-CORT125281 | Phase 1 | Healthy |
| Midazolam hydrochloride | Phase 1 | Healthy |
| mifepristone + fluvastatin | Phase 1 | Healthy Subjects |
| [14C]-CORT113176 | Phase 1 | Healthy |
| CORT118335 Oral | Phase 1 | Healthy |
| Enzalutamide | Phase 1 | Prostate Cancer |
| Risperidone | Phase 1 | Healthy |
| CORT125134 | Phase 1 | Healthy |
| Miricorilant Treatment A | Phase 1 | Healthy |
Latest
- corcept therapeutics filed 8-K
- corcept therapeutics filed 8-K
- corcept therapeutics filed 8-K
- corcept therapeutics filed 8-K
- corcept therapeutics filed 8-K
Follow Corcept Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.